Future studies, including mechanistic studies to elucidate the precise role of GPCPD1 deficiency and altered choline metabolism in HD and clinical trials to assess the efficacy and safety of citicoline as an HD treatment, are needed to address these limitations. This evidence concerns the gene GPCPD1 and Huntington disease.